Advancing Cancer Research Capability in Peru Through the Integration of Registries With Biobanks

Sandro Casavilca-Zambrano ^1,2,3, Juan Contreras-Mancilla ^1,2, Dany Córdova ^1,2

¹Banco Nacional de Tumores, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
²International Joint Laboratory of Molecular Anthropological Oncology (LOAM), INEN, IRD, Lima, Peru.
³Facultad de Ciencias de la Salud Universidad de Huánuco, Lima, Peru.
⁴Servicio de Anatomía Patológica, Hospital Clinico de la Universidad de Chile, Santiago, Chile.
⁵Departamento de Oncología Básico Clínico, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
⁶Centro para la Prevención y el Control del Cáncer (CECAN), Santiago, Chile.
⁷UMR 152 PHARMADEV, Université de Toulouse, IRD, UPS, Toulouse, France.
⁸Fundación de Pediatría Garrahan, Buenos Aires, Argentina.
⁹Hospital Británico, Buenos Aires, Argentina.
¹⁰Escuela de Medicina Humana Universidad Privada Antenor Orrego, Trujillo, Peru.
¹¹Departamento de Patología, Instituto Regional de Enfermedades Neoplásicas Norte "Dr. Luis Pinillos Ganoza," Trujillo, Peru.
¹²Departamento de Patología, Instituto Regional de Enfermedades Neoplásicas del Centro, Concepción, Peru.
¹³Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
¹⁴International Agency for Research on Cancer, Lyon, France.

⁰Banco Nacional de Tumores, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.

Biopreservation and Biobanking +

|

February 12, 2025

View abstract on PubMed

Summary

Peru established a national tumor bank network to advance cancer research, especially in underrepresented populations. This model supports genomic studies and strengthens research capacity in low- and middle-income countries.

Area Of Science

Oncology
Genomics
Public Health

Background

Peru initiated a national tumor bank network in 2005, formalized by the 2021 National Cancer Act.
The network integrates regional cancer institutes and the National Oncology Network for systematic biological sample collection.
This initiative prioritizes underrepresented populations, including those with high Amerindian ancestry.

Purpose Of The Study

To present Peru's model for establishing a national tumor bank network.
To highlight the network's role in facilitating inclusive cancer research and genomic studies.
To serve as a framework for low- and middle-income countries.

Main Methods

Systematic collection of biological samples from diverse populations.
Implementation of ethical oversight and technical standards.
Utilization of specialized management software for data sharing and integration with the Population Cancer Registry.
International collaboration with Latin American countries.

Main Results

Established a connected national tumor bank network across regional cancer institutes.
Enabled efficient data sharing and genomic research capabilities.
Documented 5992 cases, integrating tumor bank data with cancer registry information.
Enriched global genomic datasets with data from diverse and vulnerable populations.

Conclusions

Peru's national tumor bank network serves as a replicable model for low- and middle-income countries.
The network enhances cancer research capacity and promotes inclusive genomic studies.
International collaboration strengthens research efforts and data diversity for global health.

Keywords:

biobanking in low- and middle-income countries (LMICs) cancer research infrastructure genomic diversity in cancer indigenous ancestry in cancer research national tumor bank network population-based cancer registry